Cargando…
Role of IgM testing in the diagnosis and post-treatment follow-up of syphilis: a prospective cohort study
OBJECTIVES: The diagnosis of repeat syphilis and its follow-up remains challenging. We aimed to investigate if IgM testing may assist in the diagnosis of syphilis reinfection/relapse and its treatment follow-up. METHODS: This substudy was conducted in the context of a syphilis biomarker discovery st...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507855/ https://www.ncbi.nlm.nih.gov/pubmed/32958482 http://dx.doi.org/10.1136/bmjopen-2019-035838 |
_version_ | 1783585314137178112 |
---|---|
author | Osbak, Kara K Tsoumanis, Achilleas De Baetselier, Irith Van Esbroek, Marjan Smet, Hilde Kenyon, Chris R Crucitti, Tania |
author_facet | Osbak, Kara K Tsoumanis, Achilleas De Baetselier, Irith Van Esbroek, Marjan Smet, Hilde Kenyon, Chris R Crucitti, Tania |
author_sort | Osbak, Kara K |
collection | PubMed |
description | OBJECTIVES: The diagnosis of repeat syphilis and its follow-up remains challenging. We aimed to investigate if IgM testing may assist in the diagnosis of syphilis reinfection/relapse and its treatment follow-up. METHODS: This substudy was conducted in the context of a syphilis biomarker discovery study (ClinicalTrials.gov Nr: NCT02059525). Sera were collected from 120 individuals with a new diagnosis of syphilis (72 with repeat infections) and 30 syphilis negative controls during a cohort study investigating syphilis biomarkers conducted at a sexually transmitted infection/HIV clinic in Antwerp, Belgium. Syphilis was diagnosed based on a simultaneous positive treponemal and non-treponemal assay result and/or positive serum PCR targeting polA. Specimens collected at visit of diagnosis, and 3 and 6 months post-treatment were tested by two enzyme immunoassays (EIAs), recomWell (Mikrogen; MI) and Euroimmun (EU), to detect anti-treponemal IgM. Baseline specimens were also tested for anti-treponemal IgM using a line immunoassay (LIA) recomLine (MI). Quantitative kinetic decay curves were constructed from the longitudinal quantitative EIA results. RESULTS: An overall sensitivity for the diagnosis of syphilis of 59.8% (95% CI: 50.3%–68.7%), 75.0% (95% CI: 66.1%–82.3%) and 63.3% (95% CI: 54.8%–72.6%) was obtained for the EU, MI EIAs and MI LIA, respectively. When only considering repeat syphilis, the diagnostic sensitivity decreased to 45.7% (95% CI: 33.9%–58.0%), 63.9% (95% CI: 51.7%–74.6%) and 47.2% (95% CI: 35.5%–59.3%), respectively. IgM seroreverted in most cases 6 months after treatment. Post-treatment IgM concentrations decreased almost 30% faster for initial syphilis compared with repeat infection. The IgM EIAs and IgM LIA agreed from fairly to moderately (Cohen’s kappa (κ): 0.36 (EU EIA); κ: 0.53 (MI EIA); κ: 0.40 (MI LIA)) with the diagnosis of syphilis. CONCLUSIONS: IgM detection was not a sensitive method to diagnose syphilis and was even poorer in the diagnosis of syphilis repeat infections. |
format | Online Article Text |
id | pubmed-7507855 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-75078552020-10-05 Role of IgM testing in the diagnosis and post-treatment follow-up of syphilis: a prospective cohort study Osbak, Kara K Tsoumanis, Achilleas De Baetselier, Irith Van Esbroek, Marjan Smet, Hilde Kenyon, Chris R Crucitti, Tania BMJ Open Infectious Diseases OBJECTIVES: The diagnosis of repeat syphilis and its follow-up remains challenging. We aimed to investigate if IgM testing may assist in the diagnosis of syphilis reinfection/relapse and its treatment follow-up. METHODS: This substudy was conducted in the context of a syphilis biomarker discovery study (ClinicalTrials.gov Nr: NCT02059525). Sera were collected from 120 individuals with a new diagnosis of syphilis (72 with repeat infections) and 30 syphilis negative controls during a cohort study investigating syphilis biomarkers conducted at a sexually transmitted infection/HIV clinic in Antwerp, Belgium. Syphilis was diagnosed based on a simultaneous positive treponemal and non-treponemal assay result and/or positive serum PCR targeting polA. Specimens collected at visit of diagnosis, and 3 and 6 months post-treatment were tested by two enzyme immunoassays (EIAs), recomWell (Mikrogen; MI) and Euroimmun (EU), to detect anti-treponemal IgM. Baseline specimens were also tested for anti-treponemal IgM using a line immunoassay (LIA) recomLine (MI). Quantitative kinetic decay curves were constructed from the longitudinal quantitative EIA results. RESULTS: An overall sensitivity for the diagnosis of syphilis of 59.8% (95% CI: 50.3%–68.7%), 75.0% (95% CI: 66.1%–82.3%) and 63.3% (95% CI: 54.8%–72.6%) was obtained for the EU, MI EIAs and MI LIA, respectively. When only considering repeat syphilis, the diagnostic sensitivity decreased to 45.7% (95% CI: 33.9%–58.0%), 63.9% (95% CI: 51.7%–74.6%) and 47.2% (95% CI: 35.5%–59.3%), respectively. IgM seroreverted in most cases 6 months after treatment. Post-treatment IgM concentrations decreased almost 30% faster for initial syphilis compared with repeat infection. The IgM EIAs and IgM LIA agreed from fairly to moderately (Cohen’s kappa (κ): 0.36 (EU EIA); κ: 0.53 (MI EIA); κ: 0.40 (MI LIA)) with the diagnosis of syphilis. CONCLUSIONS: IgM detection was not a sensitive method to diagnose syphilis and was even poorer in the diagnosis of syphilis repeat infections. BMJ Publishing Group 2020-09-21 /pmc/articles/PMC7507855/ /pubmed/32958482 http://dx.doi.org/10.1136/bmjopen-2019-035838 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Infectious Diseases Osbak, Kara K Tsoumanis, Achilleas De Baetselier, Irith Van Esbroek, Marjan Smet, Hilde Kenyon, Chris R Crucitti, Tania Role of IgM testing in the diagnosis and post-treatment follow-up of syphilis: a prospective cohort study |
title | Role of IgM testing in the diagnosis and post-treatment follow-up of syphilis: a prospective cohort study |
title_full | Role of IgM testing in the diagnosis and post-treatment follow-up of syphilis: a prospective cohort study |
title_fullStr | Role of IgM testing in the diagnosis and post-treatment follow-up of syphilis: a prospective cohort study |
title_full_unstemmed | Role of IgM testing in the diagnosis and post-treatment follow-up of syphilis: a prospective cohort study |
title_short | Role of IgM testing in the diagnosis and post-treatment follow-up of syphilis: a prospective cohort study |
title_sort | role of igm testing in the diagnosis and post-treatment follow-up of syphilis: a prospective cohort study |
topic | Infectious Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507855/ https://www.ncbi.nlm.nih.gov/pubmed/32958482 http://dx.doi.org/10.1136/bmjopen-2019-035838 |
work_keys_str_mv | AT osbakkarak roleofigmtestinginthediagnosisandposttreatmentfollowupofsyphilisaprospectivecohortstudy AT tsoumanisachilleas roleofigmtestinginthediagnosisandposttreatmentfollowupofsyphilisaprospectivecohortstudy AT debaetselieririth roleofigmtestinginthediagnosisandposttreatmentfollowupofsyphilisaprospectivecohortstudy AT vanesbroekmarjan roleofigmtestinginthediagnosisandposttreatmentfollowupofsyphilisaprospectivecohortstudy AT smethilde roleofigmtestinginthediagnosisandposttreatmentfollowupofsyphilisaprospectivecohortstudy AT kenyonchrisr roleofigmtestinginthediagnosisandposttreatmentfollowupofsyphilisaprospectivecohortstudy AT crucittitania roleofigmtestinginthediagnosisandposttreatmentfollowupofsyphilisaprospectivecohortstudy |